MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
TScan Therapeutics, Inc. (TCRX)
TScan Therapeutics, Inc. (TCRX)
source: myfinsight.com
Download
Download image
Net (decrease)
increase in cash, cash...
-$24,349K
Stock-based compensation
$2,465K
Accounts payable
$1,045K
Accrued expense and
other liabilities
$904K
Depreciation expense
$693K
Prepaid expenses and
other assets
-$126K
Right-of-use assets and lease
liabilities, net
$16K
Net cash used in
operating activities
-$24,279K
Net cash provided by
(used in) investing...
-$70K
Canceled cashflow
$5,249K
Net loss
-$28,666K
Purchases of property and
equipment
$70K
Deferred revenue
-$982K
Back